References
- Thomas WR, Hales BJ, Smith WA. House dust mite allergens in asthma and allergy. Trends Mol. Med. 16(7), 321–328 (2010).
- Cox L, Compalati E, Kundig T, Larche M. New directions in immunotherapy. Curr. Allergy Asthma Rep. 13(2), 178–195 (2013).
- Focke M, Swoboda I, Marth K, Valenta R. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin. Exp. Allergy. 40(3), 385–397 (2010).
- Jacquet A. The role of innate immunity activation in house dust mite allergy. Trends Mol. Med. 17(10), 604–611 (2011).
- Cox L, Jacobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann. Allergy Asthma Immunol. 103(6), 451–559 (2009).
- Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol. Rev. 239(1), 62–84 (2001).
- Chua KY, Kuo IC, Huang CH. DNA vaccines for the prevention and treatment of allergy. Curr. Opin. Allergy Clin. Immunol. 9(1): 50–54 (2009).
- Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat. Rev. Genet. 9(10), 776–788 (2008).
- Sardesai NY, Weiner DB. Electroporation delivery of DNA vaccines: prospects for success. Curr. Opin. Immunol. 23(3), 421–429 (2011).
- Pulsawat P, Pitakpolrat P, Prompetchara E et al. Optimization of a Der p 2-based prophylactic DNA vaccine against house dust mite allergy. Immunol. Lett. 151(1–2), 23–30 (2013).
- Fujita H, Soyka MB, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. Clin. Transl. Allergy 2(1), 2–8 (2012).
- Weiss R, Scheiblhofer S, Thalhamer J. DNA vaccines for allergy treatment. Methods Mol. Med. 127, 253–267 (2006).
- Linhart B, Valenta R. Vaccines for allergy. Curr. Opin. Immunol. 24(3), 354–360 (2012).
- James LK, Shamji MH, Walker SM et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J. Allergy Clin. Immunol. 127, 509–516 (2011).
- Flicker S, Linhart B, Wild C, Wiedermann U, Valenta R. Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy. Immunobiology 218(6), 884–912 (2013).
- Desmet CJ, Ishii KJ. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat. Rev. Immunol. 12(7), 479–491 (2012).
- Babiuk S, Mookherjee N, Pontarollo R et al. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology 113(1), 114–120 (2004).
- Ishii KJ, Kawagoe T, Koyama S et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451(7179), 725–729 (2008).